Association of functional genes polymorphisms of key enzymes in the metabolism of biogenic amines with paranoid schizophrenia susceptibility and the influence of these polymorphisms on PANSS results in antipsychotic treatment

Archives of Psychiatry and Psychotherapy

Volumn 9, Issue 3, 2007, Pages 5-11

  Tybura, Piotr ^a   Grzywacz, Anna ^a   Konopka, Anna ^a   Samochowiec, Jerzy ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Genetics; PANSS; Schizophrenia

Indexed keywords

EID: 78049331005     PISSN: 15092046     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Frazer A, Winokur A, red. Biologiczne podstawy zaburzeń psychicznych. Warszawa: PZWL; 1982.
2. Thompson PM, Rapoport JL, Cannon TD, Toga AW. Obrazowanie mózgu w różnych fazach schizofrenii: dynamiczne i genetyczne mapy mózgu. Psychiatria po dypl. 2004, 3, 27-33.
3. Coon H, Jensen S, Holik J, Hoff M, Myles-Worsley M, Reimherr F, Wender P, Waldo M, Freedman R, Leppert M, Byerley W: Genomic scan for genes predisposing to schizophrenia. Am J Med Gen. 1994, 54, 59-71.
4. Williams NM, Rees MI, Holmans P, Norton N, Cardno AG, Jones LA, Murphy KC, Sanders RD, McCarty G, Gray MY, Fenton I, McGuffin P, Owen MJ. A two-stage genome scan for schizophrenia susceptibility genes in 196 affected sibling pairs. Human Molecular Genetics 1999, 8(9): 1729-1739. (Pubitemid 29423883)
5. Owen MJ, Williams NM, O'Donowan MC. The molecular genetics of schizophrenia: new findings promise new insights. Molecular Psychiatr. 2004, 9, 14-27.
6. McGuffin P, Owen MJ, Farmer AE. Genetic basis of schizophrenia. Lancet 1995, 346, 678-682.
7. Grossman MH, Emanuel BS, Budarf ML: Chromosomal mapping of human catecholamine-o-methyltransferase gene to 22q11.1-q11.2. Genomics 1992, 12, 822-825.
8. Dunham I, Collins J, Wadey R, Scambler P. Possible role for COMT in psychosis associated with velo-cardio-facial syndrome. Lancet 1992, 340, 1361-1362.
9. Hauser J, Kapelski P, Czerski P, Godlewski S, Dmitrzak-Wȩglarz M, Twardowska K, Rybakowski J. Brak asocjacji pomiȩdzy polimorfizmem VNTR genu DAT a schizofrenia̧. Psychiatr. Pol. 2002, 3, 413-419.
10. Lotta T, Vidgren J, Tilgmann C, Umanen I, Melen K, Julkunen I. Kinetics of human soluble and membrane bound catecholo-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 1995, 34:4202-4210.
11. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum R. Human catechol-o-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996, 6:243-250. (Pubitemid 26226317)
12. Chen Z-Y, Powell JF, Hsu Y-PP, Breakefield XO, Craig IW. Organization of the human monoamine oxidase genes and long-range physical mapping around them. Genomics 1992, 14: 75-82.
13. Sabol SZ, Hu S, Hamer D. A functional polymorphism in the monoamine oxidase A gene promoter. Human Genetics 1998, 103, 237-279.
14. World Health Organisation. International Statistical Classyfication of Diseases and Health Related Problems - Tenth Revision. WHO Collaborating Centre for Research and Training in Mental Health, 1993.
15. Robins LE, Wing J, Wittchen HU, Helzer JE, Babor TF, Burke J, Farmer A, Jablenski A, Pickens R, Riegier DA. The Composite International Diagnostic Interview: an epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatr. 1988, 45:1069-1077.
16. Kay SR, Fiszbein A, Opler L. The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia. Schizophrenia Bullet. 1987, 13/2: 261-276.
17. Miller S, Dykes D, Plesky H. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988, 16, 1215.
18. Statistical package for social sciences. Version 4.01, SSPS-Inc. München, 1991.
19. Palmatier MA, Kang AM, Kid KK. Different Catechol-o-methyltransferase alleles, Biol Psychiatr. 1999, 46:557-567.
20. Daniels JK, Williams NM, Williams J, Jones LA, Cardno AG, Murphy KC, Spurlock G, Riley B, Scamber P, Asherson P, McGuffin P, Owen MJ. No evidence for allelic association between schizophrenia and a polymorphism determining high or low catechol-o-methyltransferase activity. Am. J. Psych. 1996, 153(2): 268-270.
21. Karayiorgou M, Gogos JA, Galke BL, Wolyniec PS, Nestad G, Antonarakis SE, Kazazian HH, Housman DE, Pulver AE. Identification of sequence variant and analysis of the role of the catechol-o-methyltransferase gene in schizophrenia susceptibility, Biol Psychiatr. 1998, 43:425-431.
22. Li T, Sham PC, Vallada H, Xie T, Tang X, Murray RM, Liu X, Collier DA. Preferential transmission of the high activity allele of COMT in schizophrenia. Psychiatric Genetics 1996, 6, 131-133.
23. Kunugi H, Vallada HP, Sham PC, Hoda F, Arranz MJ, Li T, Nanko S, Murray RM, McGuffin P, Owen M, Gill M, Collier DA. Catechol-o-methyltransferase polymorphisms and schizophrenia: transmission disequilibrium study in multiply affected families. Psychiatrics Genetics 1997, 7, 97-101. (Pubitemid 27450083)
24. Ohmori O, Shinkai T, Kojima H, Terao T, Suzuki T, Mita T, Abe K. Association study of functional catechol-o-methyltransferase gene polymorphism in Japanese schizophrenics, Neuroscience Let. 1998, 243, 109-112. (Pubitemid 28109423)
25. Wei J, Hemmings GP. Lack of evidence for association between the COMT locus and schizophrenia. Psychiatric Genetics 1999, 9, 183-186. (Pubitemid 30072327)
26. Jin BF, Chang SZ, Niu FG, Xing WL, Wei WS, Hong YW, Guo YF, David SC, Lin H. Catechol-O-methyltransferase gene Val/ Met functional polymorphism and risk of schizophrenia: A large-scale association study plus meta-analysis, Biol. Psych. 2005, 2, 139-144.
27. Munafo MR, Bowes L, Clark TG, Flint J. Lack of association of the COMT (Val 158/108 Met) gene and schizophrenia: meta-analysis of case-control studies, Molecular Psychiatr. 2005, 10, 765-770.
28. Bray NJ, Buckland PR, Williams NM, Williams HJ, Norton N, Owen MJ. A haplotype implicated in schizophrenia human brain. Am J Hum Gen. 2003, 73, 152-161.
29. Herken H, Erdal ME. Catechol-o-methyltransferase gene polymorphism in symptomatology and prognosis, Psychiatric Genetics 2001, 11, 105-109.
30. Kirchheiner J, Nickchen K, Bauer M, Wong ML, Licinio J, Roots I, Brockmoller J. Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response. Molecular Psychiatr. 2004, 9, 442-473. (Pubitemid 38903502)
31. Sasaki T, Hattori M, Sakai T, Kato T, Kunugi H, Hirose T, Nanko S. The monoamine oxidase A gene and major psychosis in Japanese subjects. Biol. Psych. 1998, 9, 922-4.
32. Coron B, Campion D, Thibaut F, Dolfus S, Preterre P, Langlois S, Vasse T, Moreau V, Martin C, Charbonnier F, Laurent C, Mallet J, Petit M, Frebourg T. Association study between schizophrenia and monoamine oxidase A and B DNA polymorphisms. Psychiatry Res. 1996, 3, 221-6.
33. DeLisi LE, Wise CD, Potkin SG, Zalcman S, Phelps BH, Lovenberg W, Wyat RJ. Dopamine-beta-hydroxylase, monoamino oxydase, and schizophrenia. Biol. Psych. 1980, 6, 895-907.
34. Norton N, Kirov G, Zammit S, Jones G, Jones S, Owen R, Krawczak M, Wiliams NM, O'Donowan MC, Owem MJ. Schizophrenia and functional polymorphisms in the MAOA and COMT genes: No evidence for association or epistasis. Am J Med Genet. 2002, 5, 491-496.
35. Syagailo YV, Stober G, Grassle M, Reimer E, Knapp M, Jangkunz G, Okladnowa O, Meyer J, Lesch KP. Association analysis of the functional monoamine oxidase A gene promoter polymorphism in the psychiatric disorders. Am J Med Genet. 2001 2, 168-71.